The Asian Cohort for Alzheimer’s Disease (ACAD) is an international collaboration with the goal of compiling a robust sample size of Asian American and Canadian subjects for Alzheimer’s disease (AD) research. Making up 6% and 10% of the US and Canadian populations respectively, Asians are the fastest growing populations in both countries yet they are underrepresented in AD research. ACAD aims to address this gap by starting with a cohort of individuals of Chinese, Korean, and Vietnamese ancestry, and later extending to other major Asian populations in both countries.
Enrollment in ACAD involves a demographic questionnaire, cognitive testing, and saliva and/or blood sample for genetic analysis. These data will be used to determine the impact of lifestyle and genetic factors on AD risk.
For more information on how to participate in ACAD, please visit the procedure page.